Trilogy Capital Inc. Bruker Corp Transaction History
Trilogy Capital Inc.
- $1.89 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding BRKR
# of Institutions
395Shares Held
107MCall Options Held
494KPut Options Held
1.53M-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.4MShares$579 Million0.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$497 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.83MShares$459 Million0.01% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.48MShares$443 Million25.2% of portfolio
-
London CO Of Virginia Richmond, VA4.19MShares$196 Million1.41% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $6.92B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...